Out of pocket, Part II
Last month, I wrote about rising prescription drug costs, and made the point that a considerable portion of the cost of new drug development is borne by taxpayers (from the U.S. and other developed nations). I also noted that many drugs, including some of the newest “breakthrough” drugs, are available in other countries for a small fraction of the cost charged U.S. patients and... READ MORE
